Search of: ovarian cancer | Open Studies | received from 08/01/2010 to 09/11/2010 - List Results - ClinicalTrials.gov

Found 16 studies with search of:

ovarian cancer | Open Studies | received from 08/01/2010 to 09/11/2010

Include studies that are not seeking new volunteers.

Display Options

Rank	Status	Study
1	Not yet recruiting	Short Non-coding RNA Biomarkers of Predisposition to Ovarian Cancer Condition: Ovarian Cancer Intervention:
2	Recruiting	Consolidation Whole Abdominal Intensity-Modulated Radiation Therapy (IMRT) in Advanced Ovarian Cancer Conditions: Ovarian Cancer; Tubal Carcinoma; Primary Peritoneal Carcinoma Intervention: Radiation: intensity-modulated whole-abdominal radiotherapy
3	Recruiting	Trial of High Dose Topotecan With Carboplatin in Patients With Relapsed Ovarian Carcinoma Conditions: Ovarian Cancer; For Relapses Occuring Between 6 and 12 Months Intervention: Drug: Topotecan
4	Not yet recruiting	RO4929097 in Treating Patients With Recurrent and/or Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Conditions: Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer Interventions: Drug: gamma-secretase inhibitor RO4929097; Other: laboratory biomarker analysis
5	Recruiting	Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment Strategy Condition: Ovarian Carcinoma Intervention: Drug: Cytophosphan, Celecoxib, Methotrexate
6	Not yet recruiting	Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian Cancer Conditions: Ovarian Cancer; Primary Peritoneal Cancer; Fallopian Tube Cancer Interventions: Drug: Gemcitabine; Drug: Vinorelbine
7	Not yet recruiting	Saracatinib and Paclitaxel in Platinum-resistant Ovarian Cancer Conditions: Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer Interventions: Drug: Paclitaxel; Drug: Saracatinib; Drug: Matched placebo
8	Not yet recruiting	Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Clear Cell Ovarian Cancer Condition: Ovarian Cancer Interventions: Drug: carboplatin; Drug: paclitaxel; Drug: temsirolimus; Other: laboratory biomarker analysis
9	Not yet recruiting	Changes in Performance Status and Symptom Distress in Older Patients With Advanced Ovarian Epithelial Cancer Undergoing Surgery and/or Chemotherapy Conditions: Ovarian Cancer; Perioperative/Postoperative Complications; Psychosocial Effects of Cancer and Its Treatment Interventions: Other: medical chart review; Other: questionnaire administration; Procedure: assessment of therapy complications; Procedure: psychosocial assessment and care; Procedure: quality-of-life assessment
10	Not yet recruiting	Early Detection of Cancers in Low Resource Countries Conditions: Breast Neoplasms; Uterine Cervical Neoplasms; Ovarian Neoplasms; Endometrial Neoplasms Interventions: Procedure: Breast Cancer Screening and Diagnosis; Procedure: Cervical Cancer Screening and Diagnosis; Procedure: Ovarian Cancer Screening and Diagnosis; Procedure: Endometrial Cancer Screening and Diagnosis
11	Not yet recruiting	Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer Conditions: Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer Interventions: Biological: wild-type reovirus; Drug: paclitaxel
12	Not yet recruiting	Carboplatin and Pralatrexate in Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer Conditions: Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer Interventions: Drug: carboplatin; Drug: pralatrexate
13	Recruiting	A Controlled Study of Quality of Life and it's Related Factors Among Gynecological Cancer Survivors Conditions: Cervical Cancer; Ovarian Cancer; Endometrial Cancer Intervention:
14	Recruiting	A Phase I Study of MGAH22 in Patients With Refractory HER2 Positive Cancers Conditions: Non-Small Cell Lung Neoplasms; Prostate Neoplasms; Bladder Neoplasms; Ovarian Neoplasms; Breast Neoplasms Intervention: Drug: MGAH22
15	Recruiting	Predictors of Ovarian Insufficiency in Young Breast Cancer Patients Conditions: Breast Cancer; Ovarian Insufficiency; Ovarian Failure Intervention:
16	Recruiting	Analysis of Two Therapeutic With Cetrotide® in PolyCystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART) Condition: Polycystic Ovarian Syndrome Interventions: Drug: cetrorelix acetate; Drug: Cetrorelix acetate